Zevra Therapeutics, Inc. (ZVRA)

8.78 -0.15 (-1.68%) USD  |  NASDAQ  |  Jan 20, 09:57
More

Zevra Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for ZVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
XOMA Royalty Corp. Upgrade
Verastem, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Akebia Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade